George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 127.50
Bid: 120.00
Ask: 135.00
Change: 0.00 (0.00%)
Spread: 15.00 (12.50%)
Open: 127.50
High: 127.50
Low: 127.50
Prev. Close: 127.50
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Games Workshop And Beazley Top FTSE 250

Fri, 08th Nov 2019 10:30

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.

----------

FTSE 100 - LOSERS

----------

International Consolidated Airlines Group, down 0.5%. The British Airways parent cut its annual earnings per share growth forecast for three years from 2020 to 2022 due to reduced planned capacity growth. The Anglo-Spanish airline holding company now expects average EPS growth of 10% per annum for the three years, compared with 12% per annum estimated previously. IAG attributed the EPS guidance cut to lower planned available seat per kilometre growth, which is now predicted to be 3.4% per annum compared with around 6% per annum estimated previously for 2019 to 2023. Separately, IAG said that October traffic, measured in revenue passenger kilometres, increased by 4.8% to 24.9 million from 23.8 million a year ago. Year-to-date traffic increased 5.6% to 241.6 million revenue passenger kilometres. October capacity, measured in available seat kilometres, increased by 2.7% year-on-year to 29.4 million from 28.6 million. The company carried 10.4 million passengers in October versus 10.0 million a year ago. Load factor increased to 85.0% from 83.3%.

----------

FTSE 250 - WINNERS

----------

Games Workshop, up 14%. The wargames manufacturer and retailer guided for a solid increase in profit and revenue for the first half of its financial year. Games Workshop said its trading to November 3 has remained robust since its last update on September 18, with sales and profit ahead of the same period the year before. Royalties receivable are also significantly ahead of the prior year, driven by the timing of guarantee income on the signing of new licences. As a result, for the six months ending December 2, Games Workshop expects pretax profit to be no less than GBP55 million, and sales to be at least GBP140 million. At the very least, this reflects a 34% rise from GBP40.8 million pretax profit, and 11% from GBP125.2 million in revenue the year before.

----------

Beazley, up 7.6%. The insurer posted a 12% increase in year-to-date gross premiums due to double-digit premium growth across its business, driven by organic growth and rate rises across several business lines. For the nine months to September 30, Beazley recorded gross premiums of USD2.19 billion versus USD1.99 billion a year before. Year-to-date investment return stood at 4.0% versus 0.5%. The company, however, also warned that increased storm insurance claims will hit its 2019 combined ratio, a key profitability measure for insurers. Beazley expects a combined ratio of between 100% and 102% for 2019, assuming normalised claims levels for the remainder of the year. In 2018, the company's combined ratio was 98%. A ratio below 100% indicates that the company is making an underwriting profit, while a ratio above 100% means that it is paying out more money in claims that it is receiving from premiums.

----------

Dunelm, up 3.5%. UBS upped the home furnishings retailer to Buy From Neutral.

----------

Tate & Lyle, up 1.6%. Kepler Cheuvreux raised the supplier of food and beverage ingredients to Hold from Reduce.

----------

FTSE 250 - LOSERS

----------

IMI, down 2.4%. Morgan Stanley reduced the engineer to Equal-Weight from Overweight.

----------

G4S, down 1.5%. RBC chopped the security firm to Perform from Outperform.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

W Resources, up 13%. The tungsten, tin and gold mining company said commissioning and ramp-up activities at La Parrilla continue to advance. Over five tonnes of tungsten concentrate has been produced which will be purified and tin separated next week, W Resources said. Tungsten concentrate production for the T2 phase at La Parrilla will be underway during November. Also, W Resources said it is in advanced stages of finalising finance facilities and additional equity investment from local Spanish investors.

----------

Faron Pharmaceuticals, up 11% at 236.75. The clinical-stage biopharmaceutical company has raised GBP7.5 million through a private placing, which will go towards the clinical development of Clevegen, which is used for cancer treatment by supporting the hosts immune systems against tumours. Faron said it issued 3.9 million shares at a price of 190 pence per share, reflecting a 13% discount to its closing price of 220.00p.

----------

Savannah Petroleum, up 8.9%. The oil and gas company said it has agreed final long-form documentation in relation to Seven Energy International Ltd financial restructuring. In 2017, Savannah agreed to buy an interest in two assets of Seven Energy. As such, Savannah said the procedural transaction completion process has now commenced. As part of this process, a court hearing has been scheduled by the High Court of Justice, Business and Property Courts on Wednesday next week at which Seven Energy will request the appointment of administrators in order to effect the transfer of its assets to the group of companies controlled by Savannah and AIIM.

----------

Aura Energy, up 6.9%. The minerals company has provided Sweden a written notification under Energy Charter Treaty. Uranium in Sweden was banned in August 2018 and Aura Energy is seeking compensation for the financial loss resulting from this decision. In the trigger letter Aura Energy has requested Sweden for amicable settlement. Discussions shall be ended within a three months period, the company said.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Cap-XX, down 11%. The supercapacitors retailer reported pretax loss of USD2.8 million for the year to the end of June compared to USD2.5 million a year prior, as revenue declined to USD3.2 million from USD4.9 million. The major factor underlying this decrease was the last tranche of the "up-front" component of the AVX license being received in financial 2018, Cap-XX said. Over the past twelve months, the company said it has made "good progress" towards achieving its objectives, despite "strong headwinds" from global uncertainty around free trade and the UK's membership of the EU. Looking ahead, Cap-XX said it has entered the current financial year with a strong pipeline of enquiries and a strengthened portfolio of licensing agreements.

----------

Beowulf Mining, down 7.2%. The exploration and development company has raised GBP250,000 in gross proceeds through a share subscription to support Vardar Mineral's Mitrovica and Viti projects in Kosovo and for general working capital purposes. Beowulf said it will issue 4.3 million new ordinary at price 5.75 pence per share. At October 31, the company held GBP1.1 million in cash. The company owns about a 42% stake in Vardar Mineral, which holds exploration licences for the Mitrovica and Viti projects. On Wednesday, Beowulf invested a further GBP100,000 in Vardar Minerals, increasing its ownership to 41.5% from 40.1%.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
15 Apr 2024 10:58

Faron Pharmaceuticals reappoints former finance chief on interim basis

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it appointed a new interim chief financial officer to replace the outgoing James O'Brien.

Read more
15 Apr 2024 09:36

Faron Pharmaceuticals CFO stands down

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals revealed on Monday that chief financial officer James O'Brien would be leaving the group to "pursue another career opportunity".

Read more
8 Apr 2024 11:50

UPDATE: Faron Pharmaceuticals promotes COO to CEO as father retires

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it will promote its chief operating officer to chief executive to replace his father, the company's founder.

Read more
8 Apr 2024 11:28

Faron Pharmaceuticals promotes COO to CEO as founder steps back

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it will promote its chief operating officer to chief executive to replace the company's founder.

Read more
8 Apr 2024 09:17

Faron Pharmaceuticals taps Juho Jalkanen for CEO

(Sharecast News) - Biopharmaceutical company Faron Pharmaceuticals named Dr Juho Jalkanen as its next chief executive officer on Monday.

Read more
4 Apr 2024 11:58

Faron Pharmaceuticals secures funding to deliver next "milestones"

(Alliance News) - Faron Pharmaceuticals Ltd on Thursday said it has successfully raised funds to support the phase two study of its bexmarilimab cancer treatment.

Read more
3 Apr 2024 10:59

TRADING UPDATES: Quiz sales fall, names new CEO; Byotrol eyes AIM exit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
2 Apr 2024 13:22

UK shareholder meetings calendar - next 7 days

Wednesday 3 April 
Downing Strategic Micro-Cap Investment Trust PLCGM re approval of B share scheme
Quantum Exponential Group PLCGM re delisting or potential investment in company
Thursday 4 April 
Rio Tinto PLCAGM
Scottish American Investment Co PLCAGM
TheWorks.co.uk PLCGM re Main Market delisting and AIM admission
Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 17:09

LONDON MARKET CLOSE: Stocks downbeat before central bank rate storm

(Alliance News) - Stocks in London closed in the red on Monday, as tech gains in New York failed to make an impact ahead of several interest rate decisions from central banks across the world this week.

Read more
18 Mar 2024 14:14

Faron shares jump on encouraging trial data

(Sharecast News) - Faron Pharmaceuticals announced further encouraging data from the first phase of its 'BEXMAB' trial on Monday, targeting higher-risk (HR) myelodysplastic syndrome (MDS) patients who had failed prior hypomethylating agent (HMA) treatment.

Read more
18 Mar 2024 11:41

Faron Pharmaceuticals shares jump on positive data from Bexmab study

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said a study showed more patients responding to treatment in a new readout of the Bexmab study focused on myelodysplastic syndrome, or MDS.

Read more
18 Mar 2024 10:05

AIM WINNERS & LOSERS: Clontarf raises GBP400,000; Faron jumps

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
13 Mar 2024 20:49

EARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 Mar 2024 11:52

Faron Pharmaceuticals reports year of clinical progress

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals reported a year of strong progress on Wednesday, with significant overall response rates seen in both previously hypomethylating agent (HMA)-failed and higher-risk myelodysplastic syndrome (MDS) patient populations in the phase one part of the BEXMAB study.

Read more
6 Mar 2024 16:06

UK earnings, trading statements calendar - next 7 days

Thursday 7 March 
Admiral Group PLCFull Year Results
Aviva PLCFull Year Results
Beazley PLCFull Year Results
Brooks Macdonald Group PLCHalf Year Results
Coats Group PLCFull Year Results
Darktrace PLCHalf Year Results
Elementis PLCFull Year Results
Entain PLCFull Year Results
Funding Circle Holdings PLCFull Year Results
Harbour Energy PLCFull Year Results
ITV PLCFull Year Results
Kier Group PLCFull Year Results
Melrose Industries PLCFull Year Results
Nexus Infrastructure PLCFull Year Results
PageGroup PLCFull Year Results
Physiomics PLCHalf Year Results
Rentokil Initial PLCFull Year Results
Robert Walters PLCFull Year Results
Spirax-Sarco Engineering PLCFull Year Results
TT Electronics PLCFull Year Results
Tyman PLCFull Year Results
Friday 8 March 
Informa PLCFull Year Results
Just Group PLCFull Year Results
LMS Capital PLCFull Year Results
Stelrad Group PLCFull Year Results
Monday 11 March 
HgCapital Trust PLCFull Year Results
Mincon Group PLCFull Year Results
MTI Wireless Edge LtdFull Year Results
Tuesday 12 March 
BATM Advanced Communications LtdFull Year Results
Costain Group PLCFull Year Results
Domino's Pizza Group PLCFull Year Results
Fonix Mobile PLCHalf Year Results
Foresight Solar Fund LtdFull Year Results
Genuit PLCFull Year Results
H&T Group PLCFull Year Results
Hill & Smith PLCFull Year Results
MaxCyte IncFull Year Results
Persimmon PLCFull Year Results
Synthomer PLCFull Year Results
Target Healthcare REIT PLCHalf Year Results
TI Fluid Systems PLCFull Year Results
TP ICAP Group PLCFull Year Results
Wednesday 13 March 
4imprint Group PLCFull Year Results
Advanced Medical Solutions Group PLCFull Year Results
Balfour Beatty PLCFull Year Results
Centaur Media PLCFull Year Results
Faron Pharmaceuticals LtdFull Year Results
Ferrexpo PLCFull Year Results
Gym Group PLCFull Year Results
Hochschild Mining PLCFull Year Results
IP Group PLCFull Year Results
Keywords Studios PLCFull Year Results
Kin & Carta PLCHalf Year Results
Metro Bank Holdings PLCFull Year Results
Nexteq PLCFull Year Results
PensionBee Group PLCFull Year Results
Public Policy Holding Co IncFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Supermarket Income REIT PLCHalf Year Results
Trainline PLCTrading Statement
Vaalco Energy IncFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.